POLARx Cardiac Cryoablation System Study

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

September 26, 2022

Study Completion Date

September 26, 2022

Conditions
Atrial Fibrillation
Interventions
DEVICE

Boston Scientific Cardiac Cryoablation System

cryoablation of atrial fibrillation consisting in electrical isolation of the pulmonary veins

Trial Locations (19)

Unknown

UZ Brussel, Brussels

Klinicki Bolnicki Centar, Split

CHU De Brest - Hopital de la Cavale Blanche, Brest

CHU De Caen, Caen

CHU Grenoble - Hopital Michallon, Grenoble

Clinique Pasteur, Toulouse

CHRU Hospital Trousseau, Tours

Herz-und Diabeteszentrum Nordrhein-Westfalen, Bad Oeynhausen

Vivantes Klinikum Am Urban, Berlin

Staedtisches Klinikum Karlsruhe, Karlsruhe

Universitaetsklinikum Schleswig-Holstein, Lübeck

Maria Cecilia Hospital SPA, Cotignola

Centro Cardiologico Monzino, Milan

Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina, Roma

Erasmus MC, Rotterdam

Isala Klinieken, Zwolle

Papworth Hospital, Cambridge

Liverpool Heart and Chest Hospital, Liverpool

Freeman Hospital, Newcastle upon Tyne

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY